RxDoctor Payments Data

Anne Growney, PA

Physician Assistant · Jacksonville, NCNPI 1457897282

Payments from drug & device makers

$2,121in general payments, 2019–2025

Across 105 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$410
  • Jazz Pharmaceuticals Inc.$270
  • Harmony Biosciences LLC$258
  • Bayer$205
  • Avadel CNS Pharmaceuticals, LLC$162
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$158
  • plus $658 from 15 others

What the payments were for

  • Food & beverage$2,05297%
  • Education$693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,121 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$67,897
Medicare patients
308
Services billed
906

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban141$146,477
EntrestoSacubitril/Valsartan59$59,521
OzempicSemaglutide32$31,319
XareltoRivaroxaban20$23,483
VerquvoVericiguat15$20,972
FarxigaDapagliflozin Propanediol23$19,828
JardianceEmpagliflozin11$11,249
Metoprolol Succinate120$1,713
Ranolazine ErRanolazine29$1,571
Bumetanide31$1,468
Carvedilol91$1,045
Atorvastatin Calcium69$811
Flecainide Acetate28$729
Spironolactone58$615
Losartan Potassium37$547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$38$59,52159 claims
Novo NordiskOzempic$43$31,31932 claims
Johnson & JohnsonXarelto$15$23,48320 claims
MerckVerquvo$410$20,97215 claims
AstraZenecaFarxiga$16$19,82823 claims
Boehringer IngelheimJardiance$17$11,24911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Jacksonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →